13:23:11 EST Thu 22 Feb 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:AEZS from 2023-02-23 to 2024-02-22 - 20 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-02-15 18:01C:AEZSAeterna Zentaris Inc (4)2.41News ReleaseAeterna urges shareholders to approve Ceapro merger
2023-12-14 09:27C:AEZSAeterna Zentaris Inc (4)2.90News ReleaseAeterna Zentaris, Ceapro sign definitive merger deal
2023-12-14 08:11C:AEZSAeterna Zentaris Inc (4)2.90Resume TradingAeterna Zentaris resuming at the open
2023-12-14 07:58C:AEZSAeterna Zentaris Inc (4)2.90Halt TradingAeterna Zentaris halted at the open
2023-11-09 13:55C:AEZSAeterna Zentaris Inc (4)News ReleaseAeterna Zentaris loses $4.1-million (U.S.) in Q3
2023-11-09 10:10C:AEZSAeterna Zentaris Inc (4)2.14SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-09 10:07C:AEZSAeterna Zentaris Inc (4)2.14SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-09 14:26C:AEZSAeterna Zentaris Inc (4)3.90News ReleaseAeterna Zentaris loses $2.5-million (U.S.) in Q2 2023
2023-08-09 08:19C:AEZSAeterna Zentaris Inc (4)3.90SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-13 12:30C:AEZSAeterna Zentaris Inc (4)3.77News ReleaseAeterna sees positive preclinical data for AIM proteins
2023-06-14 16:39C:AEZSAeterna Zentaris Inc (4)News ReleaseAeterna Zentaris shareholders approve AGM resolutions
2023-05-09 19:00C:AEZSAeterna Zentaris Inc (4)3.91News ReleaseAeterna loses $4.3-million (U.S.) in Q1
2023-05-09 17:08C:AEZSAeterna Zentaris Inc (4)3.91SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-09 17:08C:AEZSAeterna Zentaris Inc (4)3.91SEDAR MD & ASEDAR MD & A
2023-04-05 09:11C:AEZSAeterna Zentaris Inc (4)3.39News ReleaseAeterna to stop sales of Macrilen in U.S. May 23
2023-03-23 12:40C:AEZSAeterna Zentaris Inc (4)3.65News ReleaseAeterna Zentaris loses $22.7-million (U.S.) in 2022
2023-03-23 08:14C:AEZSAeterna Zentaris Inc (4)3.65SEDAR Annual ReportSEDAR Annual Report
2023-03-23 08:13C:AEZSAeterna Zentaris Inc (4)3.65SEDAR MD & ASEDAR MD & A
2023-03-23 08:08C:AEZSAeterna Zentaris Inc (4)3.65SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-03-16 11:26C:AEZSAeterna Zentaris Inc (4)3.65News ReleaseAeterna partner licenses Ghryvelin to Pharmanovia